Skip to content

Effect of Bioptron Light on Carpal Tunnel Syndrome(BLCTS)

Effect of Bioptron Light Therapy on Pregnancy Related Carpal Tunnel Syndrome

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06209918
Enrollment
62
Registered
2024-01-18
Start date
2023-07-01
Completion date
2024-12-31
Last updated
2024-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel Syndrome Pregnancy

Keywords

Bioptron light therapy, Phototherapy, Carpal tunnel syndrome

Brief summary

The purpose of this study is to investigate the effect of bioptron light therapy on pregnancy related carpal tunnel syndrome

Detailed description

Carpal tunnel syndrome (CTS) is a symptomatic compression neuropathy of the median nerve at the level of the wrist, characterized by hand pain, numbness, and tingling in the distribution of the median nerve (thumb, index, middle finger, and the radial side of the ring finger) and a reduction in grip strength and hand function. The severity of symptoms can be clinically categorized into mild, moderate, and severe Bioptron phototherapy acts as a sterile trigger on human in vitro isolated peripheral blood mononuclear cells (PBMCs), affecting their cytokine production and driving the immune response towards an anti-inflammatory/reparative profile and representing a non-pharmaceutical and non-invasive option for several clinical conditionsA randomized control study, the women will be randomly assigned into two groups, (31 women for each group) equal in number. Group (A) will include 31 women will receive Bioptron light combined with advice and patient education (10 minutes per session, 3 sessions per week, for 4 weeks). Group (B) will be receiving advice only for same duration as group (A)

Interventions

patient will be sitting on comfortable chair with the hand placed on an armrest in an extended and supinated position. Firstly, the skin over the wrist area will be exposed and cleaned by alcohol to achieve maximal penetration of light. Then, the bioptron device will be held perpendicular to the surface of the treated area, at a distance of 10 cm.

DEVICEwrist brace

will keep the wrist in a neutral position, not bent back or bent down too far

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

* Pregnant females clinically daignosed with carpal tunnel syndrome at least 1 month * age will range from (25-35) years. * body mass index (BMI) will be (BMI ≤ 35 kg/m2)

Exclusion criteria

* history of neurologic disease * hand surgery * hand trauma, * diabetes mellitus * cervical spondylosis * osteoarthritis of cervical spine and wrist joint * chronic renal failure * heart failure * connective tissue disorders

Design outcomes

Primary

MeasureTime frameDescription
Nerve conduction studies (NCS)4 weeksassess sensory and motor nerve conduction velocity,gf and sensory nerve action potential

Secondary

MeasureTime frameDescription
Visual analogue scale4 weeksassess pain intensity

Other

MeasureTime frameDescription
Boston carpal tunnel questionnaire4 weeksAssess Symptom severity and functional capacity

Countries

Egypt

Contacts

Primary ContactSara Ma Ahmed, lecturer
saramagdy87@cu.edu.eg01063998331

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026